{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:46:53Z","timestamp":1776836813786,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.amjoto.2024.104236","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T16:27:01Z","timestamp":1708792021000},"page":"104236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of Elexacaftor\u2013Tezacaftor\u2013Ivacaftor on chronic rhinosinusitis in cystic fibrosis"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-1337","authenticated-orcid":false,"given":"Stefano","family":"Di Gioia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Venditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cipolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9678","key":"10.1016\/j.amjoto.2024.104236_bb0005","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O\u2019Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2024.104236_bb0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.amjoto.2024.104236_bb0015","doi-asserted-by":"crossref","unstructured":"Scotet V, L'Hostis C, F\u00e9rec C. The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes (Basel). 2020;11(6):589. Published 2020 May 26. doi:https:\/\/doi.org\/10.3390\/genes11060589.","DOI":"10.3390\/genes11060589"},{"issue":"1","key":"10.1016\/j.amjoto.2024.104236_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s40136-017-0139-3","article-title":"Medical and surgical advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis","volume":"5","author":"Tipirneni","year":"2017","journal-title":"Curr Otorhinolaryngol Rep"},{"issue":"6","key":"10.1016\/j.amjoto.2024.104236_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.2008.104711","article-title":"Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis","volume":"64","author":"Mainz","year":"2009","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.amjoto.2024.104236_bb0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/alr.22067","article-title":"Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis","volume":"8","author":"Choi","year":"2018","journal-title":"Int Forum Allergy Rhinol."},{"issue":"6","key":"10.1016\/j.amjoto.2024.104236_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2012.04.011","article-title":"Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response","volume":"11","author":"Johansen","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.amjoto.2024.104236_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcf.2010.12.002","article-title":"Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis","volume":"10","author":"Aanaes","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.amjoto.2024.104236_bb0045","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00405-014-3322-x","article-title":"Sinus biofilms in patients with cystic fibrosis: is adjusted eradication therapy needed?","volume":"272","author":"Aanaes","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.amjoto.2024.104236_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4193\/Rhino14.300","article-title":"Reduced effect of intravenous antibiotic treatment on sinonasal markers in pulmonary inflammation","volume":"53","author":"Doht","year":"2015","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104236_bb0055","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58(Suppl S29):1-464","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"3","key":"10.1016\/j.amjoto.2024.104236_bb0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/lio2.401","article-title":"Chronic rhinosinusitis in patients with cystic fibrosis-current management and new treatments","volume":"5","author":"Johnson","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"4","key":"10.1016\/j.amjoto.2024.104236_bb0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcf.2013.10.011","article-title":"Sinonasal manifestations of cystic fibrosis: a correlation between genotype and phenotype?","volume":"13","author":"Berkhout","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.amjoto.2024.104236_bb0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.amjoto.2024.104236_bb0075","unstructured":"Cystic Fibrosis mutation database maintained by the Cystic Fibrosis Centre at the Hospital for Sick Children in Toronto. http:\/\/www.genet.sickkids.on.ca\/StatisticsPage.html Accessed October 10, 2023."},{"key":"10.1016\/j.amjoto.2024.104236_bb0080","unstructured":"Food and Drug Administration. Elexacaftor-Tezacaftor-Ivacaftor. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212273s008lbl.pdf Accessed February 7, 2023."},{"key":"10.1016\/j.amjoto.2024.104236_bb0085","unstructured":"European Medicines Agency. Elexacaftor-Tezacaftor-Ivacaftor. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio Accessed February 7, 2023."},{"issue":"3 Pt 2","key":"10.1016\/j.amjoto.2024.104236_bb0090","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2024.104236_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/000348949510410s02","article-title":"Quantification for staging sinusitis. The staging and therapy group","volume":"167","author":"Lund","year":"1995","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"issue":"3","key":"10.1016\/j.amjoto.2024.104236_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2500\/ajra.2009.23.3324","article-title":"Radiological sinonasal findings in adults with cystic fibrosis","volume":"23","author":"Orlandi","year":"2009","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"10.1016\/j.amjoto.2024.104236_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/alr.22716","article-title":"Impact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis","volume":"11","author":"Douglas","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.amjoto.2024.104236_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.amjoto.2024.104236_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1513\/AnnalsATS.202101-057OC","article-title":"Impact of cystic fibrosis transmembrane conductance regulator therapy on chronic rhinosinusitis and health status: deep learning CT analysis and patient-reported outcomes","volume":"19","author":"Beswick","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.amjoto.2024.104236_bb0120","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.amjoto.2024.104236_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2023.2701","article-title":"Elexacaftor-Tezacaftor-Ivacaftor therapy for chronic sinus disease in cystic fibrosis","author":"Sheikh","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9","key":"10.1016\/j.amjoto.2024.104236_bb0130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/alr.22953","article-title":"The management of cystic fibrosis chronic rhinosinusitis: an evidenced-based review with recommendations","volume":"12","author":"Spielman","year":"2022","journal-title":"Int Forum Allergy Rhinol."},{"issue":"1","key":"10.1016\/j.amjoto.2024.104236_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00405-021-06875-6","article-title":"Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options","volume":"279","author":"Krajewska","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2024.104236_bb0140","article-title":"Medical interventions for chronic rhinosinusitis in cystic fibrosis","volume":"4(4):CD012979","author":"Karanth","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjoto.2024.104236_bb0145","doi-asserted-by":"crossref","unstructured":"Walters ZA, Sedaghat AR, Phillips KM. Acute exacerbations of chronic rhinosinusitis: The current state of knowledge. Laryngoscope Investig Otolaryngol. 2022;7(4):935\u2013942. Published 2022 Jul 20. doi:https:\/\/doi.org\/10.1002\/lio2.857.","DOI":"10.1002\/lio2.857"},{"issue":"6","key":"10.1016\/j.amjoto.2024.104236_bb0150","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/all.13409","article-title":"Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status","volume":"73","author":"Kuiper","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.amjoto.2024.104236_bb0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/lary.26901","article-title":"Relationship between chronic rhinosinusitis exacerbation frequency and asthma control","volume":"128","author":"Banoub","year":"2018","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.amjoto.2024.104236_bb0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal outcome test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019607092400022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019607092400022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T22:38:06Z","timestamp":1714775886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019607092400022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S019607092400022X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104236","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Elexacaftor\u2013Tezacaftor\u2013Ivacaftor on chronic rhinosinusitis in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104236"}}